Navigation Links
Landmark National Survey Conducted by Harris Interactive® Sheds Light on Hidden Problem of Heavy Monthly Periods
Date:9/14/2010

PARSIPPANY, N.J., Sept. 14 /PRNewswire/ -- Nearly ninety percent of women who experience heavy periods(1) believe their life during their period would greatly improve if they could reduce their menstrual flow, according to a new Harris Interactive® survey commissioned by Ferring Pharmaceuticals. Living With HMB: A National Survey of 500 Women found that many women experience monthly periods that are so heavy they can sap energy, cause anemia, and in many ways interfere with daily activities.  However, many women accept a heavy period as normal or are embarrassed to discuss it, and may be unaware that there are new treatment options available that can help provide substantial relief.  

The survey of women ages 18-49, which was conducted online in June 2010, found that cyclic heavy menstrual bleeding (HMB), a condition also known as menorrhagia, has a significant negative impact on women's social, leisure, and physical activities.  Survey responses show that many cannot even manage work, family, and household responsibilities during their period as a result of the condition:

I am unable to do any activity that will keep me away from a restroom for more than about 90 minutes--so most outdoor activities are out of the question, and doing things like seeing movies, going to plays, etc. are a serious challenge unless there is an intermission built in or I duck out partway through.  Age 31, Very Heavy, Impact: A lot

Sometimes I have to stay home from work.  When I can go to work I have to skip meetings or other events and stay in my office.  I visit the restroom up to 10 times during an 8 hour work day. Age 46, Very Heavy, Impact: A Great Deal

I usually have to call in to work. I can't play in the park with my kids or go swimming with them because I'm afraid that I will soak through my pants and everyone will see. Age 22, Very Heavy, Impact: A Great Deal

It is estimated tha
'/>"/>

SOURCE Ferring Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbotts Carotid Stent System and Surgery
2. US HIFU to Fund Landmark Investigation of Focal Therapy for Prostate Cancer
3. BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark
4. Landmark Study in The Lancet Oncology Shows Capecitabine (Xeloda(R)) Combination Therapy Reduces Early Breast Cancer Recurrence
5. ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis
6. Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet
7. Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
8. Landmark Study in The New England Journal of Medicine Shows HPV Testing Significantly Reduces Deaths from Cervical Cancer, Compared to other Methods Including Pap
9. New England Journal of Medicine Publishes Results from Boston Scientifics Landmark SYNTAX(TM) Trial
10. New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation
11. Landmark Study Demonstrates Potential of Radioimmunotherapy for Treatment of Indolent B-Cell Non-Hodgkins Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... July 31, 2015 According to a ... (Moist Heat, Dry Heat, Ethylene Oxide, Filtration, E-beam, Gamma), Services ... (Hospitals, Pharmaceuticals) - Global Forecast to 2020", published by MarketsandMarkets, ... 6.1 Billion by 2020, at a CAGR of 7.6%.from 2015 ... market data T ables and 37 ...
(Date:7/31/2015)... and SAN DIEGO , July 31, ... company Eisai Co., Ltd. (Headquarters: Tokyo ... and Halozyme Therapeutics, Inc. (Headquarters: San Diego, ... Torley , "NASDAQ: HALO") have signed a clinical collaboration ... ® , "eribulin") in combination with Halozyme,s investigational drug ...
(Date:7/30/2015)... Mettler-Toledo International Inc. (NYSE: MTD ) today announced ... highlights: , Sales in local currency increased ... Reported sales decreased 4% as currency reduced sales growth ... per diluted share as reported (EPS) were $2.73, compared ... $2.80 , an increase of 9% over the ...
Breaking Medicine Technology:Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 2Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 3Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 14
... , Feb. 4 Accuray Incorporated (Nasdaq: ARAY ), ... for the second quarter of fiscal year 2010, ended December 31, ... reported total revenue of $57.3 million , compared to the second ... , Accuray reported a net loss for the second quarter of fiscal ...
... , , ATLANTA , Feb. ... for Economic and Clinical Health (HITECH) Act, Elekta has expanded its ... advantage of the financial incentives available from the federal government. These ... certified EMR systems who are able to demonstrate meaningful use. , ...
Cached Medicine Technology:Accuray Announces Results for Second Quarter Fiscal 2010 2Accuray Announces Results for Second Quarter Fiscal 2010 3Accuray Announces Results for Second Quarter Fiscal 2010 4Accuray Announces Results for Second Quarter Fiscal 2010 5Accuray Announces Results for Second Quarter Fiscal 2010 6Accuray Announces Results for Second Quarter Fiscal 2010 7Accuray Announces Results for Second Quarter Fiscal 2010 8Accuray Announces Results for Second Quarter Fiscal 2010 9Accuray Announces Results for Second Quarter Fiscal 2010 10Accuray Announces Results for Second Quarter Fiscal 2010 11Accuray Announces Results for Second Quarter Fiscal 2010 12Elekta Expands Consultative Services Program to Help MOSAIQ Customers Demonstrate Meaningful Use Guidelines 2Elekta Expands Consultative Services Program to Help MOSAIQ Customers Demonstrate Meaningful Use Guidelines 3
(Date:8/2/2015)... Louisville, Ky. (PRWEB) , ... August 03, 2015 , ... ... prevent recurrence of some childhood cancers. The study is led by Kenneth G. ... at the University of Louisville in collaboration with colleagues at Kosair Children’s Hospital ...
(Date:8/1/2015)... ... 2015 , ... Back packs can be dangerous? Whaaat?! , Not the danger ... havoc on a kid's spine. With school starting again, most kids will be asking ... you are aware of how to help them prevent injuries by understanding backpack safety. ...
(Date:8/1/2015)... ME (PRWEB) , ... August 01, 2015 , ... Tina ... Retail Champions.” , Wilcoxson was given that honor by the National Retail Federation, the ... retail industry. Wilcoxson was one of three Maine business owners to be named as ...
(Date:8/1/2015)... TX (PRWEB) , ... August 01, 2015 , ... BeverlyD, ... for the March4thforWellBeing foundation, making hers the very first small business donation to kick ... look beautiful for over thirty years. Her legacy includes a complete line of raw, ...
(Date:7/31/2015)... York, New York (PRWEB) , ... July 31, 2015 , ... ... to strut their stuff, Super-Sod debuted their new type of sod called Leisure ... registered trademark application in process. , To commemorate introduction of this new type of ...
Breaking Medicine News(10 mins):Health News:UofL Physicians Conducting Vaccine Trial for Children with Relapsed Tumors at Kosair Children’s Hospital 2Health News:Local AlignLife Doctor Donates Time to Check Back Packs 2Health News:Local Retail Advocate Wins National Recognition 2Health News:March4thforWellBeing Foundation Kickoff 2Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2
... August 18, 2008Young researchers presented innovative, early-stage research ... collaborative project of the AUA Foundation and the ... 7-9, 2008. The AUA Foundation hosted the forum ... most cutting-edge research in sexual medicine. These ...
... 19 On September 18,Seabrook House, a nationally ... quarterly ,Inside MatriArk Family Center, open house,from 10:00 ... invited to check out,the 42,000-square-foot center and learn ... offer., This exciting event gives outsiders an ...
... Series A Funding of Healthcare Startup, NEW ... helps,consumers find and book doctor appointments online, today ... round of financing led by Khosla Ventures.,ZocDoc is ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080819/LATU010LOGO ), ZocDoc uses ...
... ... Practitioners, NEWPORT BEACH, Calif., Aug. ... Managed Compliance Services,Program (MCSP) for small healthcare practitioners -- the first ... is tailored to meet the HIPAA compliance,requirements of small healthcare practitioners. ...
... - Clinical evidence for unique Ranexa(R) mechanism of action ... Therapeutics,Inc. (Nasdaq: CVTX ) announced today that the ... showing that,ranolazine significantly (p<0.001) shortened the QT interval of ... LQT3. Ranolazine also,shortened cardiac relaxation time in the study., ...
... Search, RARITAN, N.J., Aug. 19 The first ... identify real-life "It Girls" who embody,confidence and reliability was ... Millennial generation, the finalists proved that intelligence,reliability, talent and ... this much talked about group. The "It Girl Essentials" ...
Cached Medicine News:Health News:New research on sexual function 2Health News:Seabrook House Welcomes Visitors to MatriArk Family Center 2Health News:Khosla Ventures Into Healthcare With ZocDoc 2Health News:Managed Compliance Services Program (MCSP) Introduced for Small Healthcare Practitioners 2Health News:Managed Compliance Services Program (MCSP) Introduced for Small Healthcare Practitioners 3Health News:Journal of Cardiovascular Electrophysiology Publishes Data Showing Ranolazine Shortened QT Interval and Improved Cardiac Relaxation in Study of Patients With Long QT Syndrome 2Health News:Journal of Cardiovascular Electrophysiology Publishes Data Showing Ranolazine Shortened QT Interval and Improved Cardiac Relaxation in Study of Patients With Long QT Syndrome 3Health News:Reliability & Confidence Define a Nation Of 'It Girls' 2Health News:Reliability & Confidence Define a Nation Of 'It Girls' 3Health News:Reliability & Confidence Define a Nation Of 'It Girls' 4Health News:Reliability & Confidence Define a Nation Of 'It Girls' 5
Provides outstanding patient warming and safety throughout the hospital and is nearly half the size and one-third the weight of earlier units....
The SnuggleWarm Convective Warming provides the technology and the tools to effectively enhance the quality of patient care....
The product, which is comprised of a non-intrusive panty-liner, offers a simple to use classification tool that uses color identification for interpretation of the results....
The Affirm™ VPIII tests RNA probe technology offers a dependable, rapid means toward early identification and treatment of patients suffering from these pathogens....
Medicine Products: